Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea
· Delayed Price · Currency is KRW 14,640
+2,280 (18.45%)
At close: Mar 31, 2025, 3:30 PM KST
KRX:271980 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | -29,968 | 5,005 | -13,091 | -12,473 | 6,916 | Upgrade
|
| Depreciation & Amortization | 11,297 | 9,767 | 8,886 | 9,133 | 8,993 | Upgrade
|
| Loss (Gain) From Sale of Assets | -7.97 | -0.53 | -9.99 | -30 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 478.3 | - | - | -607.15 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -359.57 | 201.1 | -2,065 | -189.64 | -67 | Upgrade
|
| Loss (Gain) on Equity Investments | -586.8 | -815.1 | 142.25 | -1,801 | -653.05 | Upgrade
|
| Stock-Based Compensation | 1,026 | 578.03 | 472.48 | 163.17 | 80.04 | Upgrade
|
| Provision & Write-off of Bad Debts | -1,041 | -2,096 | -370.58 | 1,626 | 127.48 | Upgrade
|
| Other Operating Activities | 36,147 | 3,069 | 6,044 | 8,663 | 5,345 | Upgrade
|
| Change in Accounts Receivable | -8,235 | -10,856 | -7,984 | 10,157 | 161.51 | Upgrade
|
| Change in Inventory | 369.35 | -10,575 | 3,562 | 6,334 | -26,618 | Upgrade
|
| Change in Accounts Payable | -10,390 | -7,620 | -1,664 | 9,625 | -6,487 | Upgrade
|
| Change in Other Net Operating Assets | 4,483 | 8,362 | -9,069 | -11,498 | -6,844 | Upgrade
|
| Operating Cash Flow | 3,213 | -4,981 | -15,147 | 19,100 | -19,046 | Upgrade
|
| Capital Expenditures | -4,278 | -6,097 | -11,085 | -5,344 | -2,410 | Upgrade
|
| Sale of Property, Plant & Equipment | 8.35 | 87.64 | 10 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -2,335 | -3,436 | -5,873 | 91.43 | -438.27 | Upgrade
|
| Investment in Securities | -1,313 | -2,524 | 1,898 | -845.47 | -2,912 | Upgrade
|
| Other Investing Activities | 620.43 | 51.01 | 126.46 | 60.95 | 183.77 | Upgrade
|
| Investing Cash Flow | -7,297 | -11,919 | -12,924 | -8,037 | -5,577 | Upgrade
|
| Short-Term Debt Issued | 6,228 | 24,196 | 16,410 | - | 24,419 | Upgrade
|
| Total Debt Issued | 6,228 | 24,196 | 16,410 | - | 24,419 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -6,253 | - | Upgrade
|
| Long-Term Debt Repaid | -2,199 | -4,702 | -7,448 | -8,343 | -7,987 | Upgrade
|
| Total Debt Repaid | -2,199 | -4,702 | -7,448 | -14,596 | -7,987 | Upgrade
|
| Net Debt Issued (Repaid) | 4,029 | 19,494 | 8,962 | -14,596 | 16,433 | Upgrade
|
| Repurchase of Common Stock | - | - | -396.98 | -810.02 | -314.88 | Upgrade
|
| Dividends Paid | -728.38 | -728.38 | -947.74 | -1,022 | -1,023 | Upgrade
|
| Other Financing Activities | 19,762 | -0 | 26,001 | 27,498 | 38 | Upgrade
|
| Financing Cash Flow | 23,063 | 18,766 | 33,618 | 11,069 | 15,133 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1,506 | -321.57 | -63.8 | -62.04 | -131.82 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -0 | -0 | -0 | Upgrade
|
| Net Cash Flow | 20,485 | 1,545 | 5,483 | 22,070 | -9,622 | Upgrade
|
| Free Cash Flow | -1,065 | -11,077 | -26,232 | 13,756 | -21,457 | Upgrade
|
| Free Cash Flow Margin | -0.15% | -1.52% | -3.63% | 1.96% | -3.10% | Upgrade
|
| Free Cash Flow Per Share | -73.10 | -759.19 | -1799.81 | 941.63 | -1468.17 | Upgrade
|
| Cash Interest Paid | 4,183 | 4,255 | 1,805 | 921.03 | 1,052 | Upgrade
|
| Cash Income Tax Paid | 2,103 | 1,643 | -877.05 | 3,540 | 6,960 | Upgrade
|
| Levered Free Cash Flow | -33,199 | 2,881 | 4,052 | 20,240 | -21,666 | Upgrade
|
| Unlevered Free Cash Flow | -30,039 | 6,652 | 5,933 | 21,469 | -20,997 | Upgrade
|
| Change in Net Working Capital | 23,129 | -862.86 | -22,337 | -24,077 | 34,907 | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.